Clearstead Advisors’s Tectonic Therapeutic TECX Stock Holding History

Clearstead Advisors’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$572K	Sell	16,630 -10,130	-38%	-$298K	0.01%	713
2026 Q1	$827K	Buy	26,760 +20,260	+312%	+$499K	0.01%	578
2025 Q4	$136K	Buy	6,500 +5,000	+333%	+$92.9K	﹤0.01%	1031
2025 Q3	$23.5K	Hold	1,500	–	–	﹤0.01%	1574
2025 Q2	$29.8K	Hold	1,500	–	–	﹤0.01%	1459
2025 Q1	$26.6K	Sell	1,500 -2,333	-61%	-$76K	﹤0.01%	1339
2024 Q4	$177K	Sell	3,833 -83	-2%	-$3.51K	﹤0.01%	888
2024 Q3	$119K	Sell	3,916 -4,224	-52%	-$77.2K	﹤0.01%	987
2024 Q2	$134K	Buy	+8,140	New	+$130K	﹤0.01%	933

Other funds holding TECX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Clearstead Advisors's TECX Position: Q2 2026 in Review

Clearstead Advisors reduced its Tectonic Therapeutic (TECX) stake by 38% in Q2 2026, selling an estimated $298K and leaving 16,630 shares worth $572K. The position accounts for 0.01% of the portfolio, ranked #713.

Clearstead Advisors first reported a position in TECX in Q2 2024 and has held it in 9 quarters since. The position peaked at $827K in Q1 2026. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

Clearstead Advisors held 16,630 shares of Tectonic Therapeutic worth $572K as of Q2 2026.
Clearstead Advisors sold 10,130 Tectonic Therapeutic shares in Q2 2026, an estimated $298K.
Tectonic Therapeutic made up 0.01% of Clearstead Advisors's portfolio in Q2 2026, its #713 holding.
Clearstead Advisors first reported a position in Tectonic Therapeutic in Q2 2024 and has held it in 9 quarters since.
Clearstead Advisors's Tectonic Therapeutic position peaked at $827K in Q1 2026.
123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.